Noventra Pharma Retewxa Hybrid Pre-Filled pen is a advanced metabolic and regenerative hybrid blend combining Retatrutide and Naltrexone. Activates key receptors to boost fat loss, curb cravings, enhance mood, and support cellular repair for lasting metabolic health.

.

📋 Product Specifications:

Active Compound: Retatrutide + Naltrexone

Strength: 44mg

Brand: Noventra Pharma

Category: Weight Loss Peptide

Quality: Pharmaceutical Grade

Testing: Third-Party Lab Verified

Always stick to lowest dosage possible

A “hybrid GLP” fat-loss pen combining:

Retatrutide (32 mg)

Naltrexone (12 mg)

⚙️ How it’s supposed to work

1. Retatrutide (Triple agonist)

Targets 3 receptors:

GLP-1 → appetite suppression, slower gastric emptying

GIP → improves insulin sensitivity

Glucagon receptor → increases fat burning / energy expenditure

👉 This is the next-gen compared to semaglutide/tirzepatide.

2. Naltrexone

Affects reward pathways (dopamine)

Helps reduce:

Food cravings

Emotional eating

👉 Similar concept to Contrave (but not identical dosing).

💉 Dosing shown on the box

(Important: this is manufacturer-guided, not medically standardized)

Week 1: 4 mg / 1.5 mg (~30 clicks)

Week 2–3: 6 mg / 2.25 mg (~45 clicks)

Week 4–5: 8 mg / 3 mg (~60 clicks)

➡️ Injected once weekly

🧠 My honest take (based on experience with clients)

✔️ The concept is powerful (triple agonist + craving control)

❌ But the product itself is questionable

This is NOT the same as:

Ozempic / Wegovy

Mounjaro

👀 Bottom line

Strong fat-loss potential in theory with strict protocol